Literature DB >> 11531246

Survey of the rate of PSA testing in general practice.

J Melia1, S Moss.   

Abstract

The use of prostate specific antigen (PSA) test could have a large impact on the incidence of prostate cancer in the UK. Over a period of 1 year (1999), 3.5% out of 160 015 men aged > 45 on a GP database, who had no previous record of prostate cancer, had a PSA test. Of the tested men, 21.3% had a PSA > 4 ng/ml. Future data need to distinguish between men with and without symptoms. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11531246      PMCID： PMC2364127          DOI： 10.1054/bjoc.2001.1962

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  5 in total

1.  Comparison of trends in prostate-cancer mortality in England and Wales and the USA.

Authors:  S E Oliver; D Gunnell; J L Donovan
Journal:  Lancet       Date:  2000-05-20       Impact factor: 79.321

Review 2.  Report prepared for the Health Technology Assessment panel of the NHS Executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales.

Authors:  J Chamberlain; J Melia; S Moss; J Brown
Journal:  Br J Urol       Date:  1997-05

3.  Age-specific patterns of prostate-specific antigen testing among primary care physician visits.

Authors:  M McNaughton Collins; R S Stafford; M J Barry
Journal:  J Fam Pract       Date:  2000-02       Impact factor: 0.493

4.  Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing.

Authors:  S J Jacobsen; S K Katusic; E J Bergstralh; J E Oesterling; D Ohrt; G G Klee; C G Chute; M M Lieber
Journal:  JAMA       Date:  1995-11-08       Impact factor: 56.272

5.  European randomized study of prostate cancer screening: first-year results of the Finnish trial.

Authors:  L Määttänen; A Auvinen; U H Stenman; S Rannikko; T Tammela; J Aro; H Juusela; M Hakama
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640
  5 in total
  9 in total

1.  Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines.

Authors:  F J Drummond; A-E Carsin; L Sharp; H Comber
Journal:  Ir J Med Sci       Date:  2009-06-27       Impact factor: 1.568

2.  Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.

Authors:  Cindy Ke Zhou; David P Check; Joannie Lortet-Tieulent; Mathieu Laversanne; Ahmedin Jemal; Jacques Ferlay; Freddie Bray; Michael B Cook; Susan S Devesa
Journal:  Int J Cancer       Date:  2015-11-27       Impact factor: 7.396

3.  Perception of abnormal serum prostate-specific antigen (PSA) test results amongst family practitioners.

Authors:  M A Rochester; P J Donaldson; J McLoughlin
Journal:  Ann R Coll Surg Engl       Date:  2008-07       Impact factor: 1.891

4.  PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.

Authors:  Jo Brett; Eila Watson; Paul Hewitson; Colleen Bukach; Adrian Edwards; Glyn Elwyn; Joan Austoker
Journal:  BMC Fam Pract       Date:  2005-06-09       Impact factor: 2.497

5.  Contemporary update of cancer control after radical prostatectomy in the UK.

Authors:  M H Winkler; F A Khan; M Shabir; A Okeke; M Sugiono; P McInerney; G B Boustead; R Persad; A V Kaisary; D A Gillatt
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

6.  Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia.

Authors:  N Pashayan; J Powles; C Brown; S W Duffy
Journal:  Br J Cancer       Date:  2006-07-11       Impact factor: 7.640

7.  Prostate-specific antigen testing in inner London general practices: are those at higher risk most likely to get tested?

Authors:  Paul Nderitu; Mieke Van Hemelrijck; Mark Ashworth; Rohini Mathur; Sally Hull; Alexandra Dudek; Simon Chowdhury
Journal:  BMJ Open       Date:  2016-07-12       Impact factor: 2.692

8.  Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.

Authors:  Frances J Drummond; Anne-Elie Carsin; Linda Sharp; Harry Comber
Journal:  BMC Fam Pract       Date:  2009-01-12       Impact factor: 2.497

9.  Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.

Authors:  Sabina Hussain; David Gunnell; Jenny Donovan; Sean McPhail; Freddie Hamdy; David Neal; Peter Albertsen; Julia Verne; Peter Stephens; Caroline Trotter; Richard M Martin
Journal:  BJU Int       Date:  2008-01-10       Impact factor: 5.588
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.